International Journal of Clinical Pediatric Dentistry

Register      Login

VOLUME 17 , ISSUE 6 ( June, 2024 ) > List of Articles

CASE REPORT

Bridging the Gaps: Multidisciplinary and Dental Strategies for Beckwith–Wiedemann Syndrome Management

Kanupriya Sharma, Anshuman Jamdade, Satya P Yadav, Amrita Aggarwal

Keywords : Beckwith–Wiedemann syndrome, Case report, Dental management, Multidisciplinary approach, Orofacial manifestations

Citation Information : Sharma K, Jamdade A, Yadav SP, Aggarwal A. Bridging the Gaps: Multidisciplinary and Dental Strategies for Beckwith–Wiedemann Syndrome Management. Int J Clin Pediatr Dent 2024; 17 (6):702-705.

DOI: 10.5005/jp-journals-10005-2873

License: CC BY-NC 4.0

Published Online: 22-08-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Beckwith–Wiedemann syndrome (BWS) is a genetic disorder characterized by disrupted genomic imprinting, leading to abnormal regulation of fetal growth. BWS can present at any stage of life; it is most commonly diagnosed during the neonatal period or early childhood. The cardinal features of the syndrome include macrosomia, macroglossia, abdominal wall defects, and hyperinsulinism. We have discussed the case report of a 2-year-old female patient who was diagnosed with BWS at the time of birth, with a chief complaint of a large tongue and difficulty in deglutition. We have also discussed the systemic, orofacial, and dental manifestations along with comprehensive treatment planning to aid in living an overall healthy life. Early diagnosis helps in preventing further complications of the disease and acts as a guide for future treatment planning. Dentists can provide guidance on proper oral hygiene practices, offer interventions to manage macroglossia, and collaborate with other healthcare professionals to address craniofacial abnormalities and associated functional limitations.


PDF Share
  1. Eggermann T, Perez de Nanclares G, Maher ER, et al. Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci. Clin Epigenetics 2015;7:123. DOI: 10.1186/s13148-015-0143-8
  2. Shuman C, Beckwith JB, Weksberg R. Beckwith-Wiedemann Syndrome. University of Washington; 2016.
  3. Wilfong AA, Parke JT, McCrary JA 3rd. Opsoclonus-myoclonus with Beckwith-Wiedemann syndrome and hepatoblastoma. Pediatric Neurology 1992;8(1):77–79. DOI: 10.1016/0887-8994(92)90060-c
  4. Tank ES, Kay R. Neoplasms associated with hemihypertophy, Beckwith-Wiedemann syndrome and aniridia. J Urol 1980;124(2):266–268. DOI: 10.1016/s0022-5347(17)55401-4
  5. Weinstein JM, Backonja M, Houston LW, et al. Optic glioma associated with Beckwith-Wiedemann syndrome. Pediatr Neurol 1986;2(5):308–310. DOI: 10.1016/0887-8994(86)90026-3
  6. Menard RM, Delaire J, Schendel SA. Treatment of the craniofacial complications of Beckwith-Wiedemann syndrome. Plast Reconstr Surg 1995;96(1):27–33. DOI: 10.1097/00006534-199507000-00004
  7. Wang KH, Kupa J, Duffy KA, et al. Diagnosis and management of Beckwith-Wiedemann syndrome. Front Pediatr 2020;7:562. DOI: 10.3389/fped.2019.00562
  8. Borjas Mendoza PA, Mendez MD. Beckwith-Wiedemann Syndrome. PubMed. Treasure Island (Florida): StatPearls Publishing; 2023.
  9. Brioude F, Kalish JM, Mussa A, et al. Expert consensus document: clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol 2018;14(4):229–249. DOI: 10.1038/nrendo.2017.166
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.